García-Villén Fátima, Ruiz-Alonso Sandra, Lafuente-Merchan Markel, Gallego Idoia, Sainz-Ramos Myriam, Saenz-Del-Burgo Laura, Pedraz Jose Luis
NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 01006 Vitoria-Gasteiz, Spain.
Pharmaceutics. 2021 Oct 28;13(11):1806. doi: 10.3390/pharmaceutics13111806.
The adaptation and progress of 3D printing technology toward 3D bioprinting (specifically adapted to biomedical purposes) has opened the door to a world of new opportunities and possibilities in tissue engineering and regenerative medicine. In this regard, 3D bioprinting allows for the production of tailor-made constructs and organs as well as the production of custom implants and medical devices. As it is a growing field of study, currently, the attention is heeded on the optimization and improvement of the mechanical and biological properties of the so-called bioinks/biomaterial inks. One of the strategies proposed is the use of inorganic ingredients (clays, hydroxyapatite, graphene, carbon nanotubes and other silicate nanoparticles). Clays have proven to be useful as rheological and mechanical reinforcement in a wide range of fields, from the building industry to pharmacy. Moreover, they are naturally occurring materials with recognized biocompatibility and bioactivity, revealing them as optimal candidates for this cutting-edge technology. This review deals with the use of clays (both natural and synthetic) for tissue engineering and regenerative medicine through 3D printing and bioprinting. Despite the limited number of studies, it is possible to conclude that clays play a fundamental role in the formulation and optimization of bioinks and biomaterial inks since they are able to improve their rheology and mechanical properties, thus improving printability and construct resistance. Additionally, they have also proven to be exceptionally functional ingredients (enhancing cellular proliferation, adhesion, differentiation and alignment), controlling biodegradation and carrying/releasing actives with tissue regeneration therapeutic activities.
3D打印技术向3D生物打印(特别适用于生物医学目的)的适应与发展,为组织工程和再生医学领域带来了全新的机遇与可能。就此而言,3D生物打印能够制造定制化的结构和器官,以及定制植入物和医疗设备。由于这是一个不断发展的研究领域,目前人们的注意力集中在优化和改善所谓的生物墨水/生物材料墨水的机械和生物学性能上。提出的策略之一是使用无机成分(粘土、羟基磷灰石、石墨烯、碳纳米管和其他硅酸盐纳米颗粒)。从建筑行业到制药业,粘土已被证明在广泛领域中作为流变学和机械增强材料非常有用。此外,它们是天然存在的材料,具有公认的生物相容性和生物活性,这表明它们是这项前沿技术的理想候选材料。本综述探讨了通过3D打印和生物打印将粘土(天然和合成)用于组织工程和再生医学的情况。尽管研究数量有限,但可以得出结论,粘土在生物墨水和生物材料墨水的配方和优化中起着至关重要的作用,因为它们能够改善其流变学和机械性能,从而提高可打印性和结构抗性。此外,它们还被证明是极具功能性的成分(促进细胞增殖、粘附、分化和排列),能够控制生物降解并携带/释放具有组织再生治疗活性的活性物质。